We therefore hypothesize that the regulatory NLRs, NLRX1 and NLRP12, have a pertinent role in maintaining proper innate immune responses and microbiome homeostasis in the context of GFD, which is of relevance to CeD and NCGS. The gene discussed is NLRX1; the disease is cranioectodermal dysplasia.